Description
Indication
A PET radiopharmaceutical used for diagnostic imaging in oncology (detection, staging, and monitoring of cancers), cardiology (myocardial viability assessment), and neurology (evaluation of brain metabolism in epilepsy, dementia, and neurodegenerative disorders). It reflects cellular glucose metabolism, highlighting metabolically active tissues.
Activity Range
| Adult | ~5 – 15 mCi per patient (≈185 – 555 MBq) |
|---|---|
| Pediatric | ~0.10 – 0.14 mCi/kg, adjusted by body weight and protocol |
| Bulk Supply | Multi-dose vials typically 50 – 300+ mCi, calibrated to reference time |




